Private equity has funded the growth of biotech and healthcare at the early stages where much of the experimental innovation ...
Investment in biotech is booming. In Europe, the biotechnology and healthcare sector accounted for 20% of overall private equity investment ...
Fund administrator Crestbridge has appointed Alex di Santo as group head of private equity, taking over from Michael Johnson who ...
‘ManCo’ firm Carne Group has secured €100 million of private equity funding from Vitruvian Partners. Vitruvian will take a minority ...
Michael Johnson, group head of institutional services at fund administrator Crestbridge, talks to Funds Europe about the role investors play ...
Biotechnology – in the spotlight thanks to Covid-19 – surpasses even digital in terms of its scope to transform this ...
The UK’s first venture capital fund devoted to “psychedelic healthcare” was launched last week and will invest in “revolutionary mind-altering ...
Schroders has launched a second fund investing in life insurance-linked securities, as it moves to further strengthen its foothold in ...
Boutique asset manager Polar Capital has acquired Dalton Strategic Partnership as part of its European diversification plan in a deal ...
© 2026 Funds Europe Limited, a wholly owned subsidiary of Definite Article Media Limited. Website design by Bedazzled Publishing Services Limited.
© 2026 Funds Europe Limited, a wholly owned subsidiary of Definite Article Media Limited. Website design by Bedazzled Publishing Services Limited.
© 2026 Funds Europe Limited, a wholly owned subsidiary of Definite Article Media Limited. Website design by Bedazzled Publishing Services Limited.
© 2026 Funds Europe Limited, a wholly owned subsidiary of Definite Article Media Limited. Website design by Bedazzled Publishing Services Limited.